OOIR: Observatory of International Research

Papers

(The H4-Index of Nature Reviews Cardiology is 68. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Three different therapies to target PCSK9	856
Bariatric metabolic surgery more effective than GLP1R agonists in preventing congestive HF	613
Aggregation of big tau disrupts microtubules and causes diastolic dysfunction	561
Antibody treatment to deplete transthyretin amyloid deposits in the heart	550
Sacubitril–valsartan shows benefit in heart failure with ejection fraction of >40%	468
LIPC variant in combined hypocholesterolaemia	417
Intravascular imaging improves outcomes	361
Injectable and conductive cardiac patch	328
Basophils promote healing after MI	283
Travelling with heart failure: risk assessment and practical recommendations	251
Accelerated reduction in global cardiovascular disease is essential to achieve the Sustainable Development Goals	246
Neuroimmune axis of cardiovascular control: mechanisms and therapeutic implications	236
Screening for Helicobacter pylori infection in patients with cardiovascular and gastrointestinal disease	231
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective	227
Changing epidemiology of congenital heart disease: effect on outcomes and quality of care in adults	225
Genetics and mechanisms of thoracic aortic disease	212
Abbreviating DAPT reduces the risk of bleeding	203
Alternative defibrillation strategies improve outcomes	202
Heterogeneity of the post-infarct epicardium	196
Detection of subclinical hypertrophic cardiomyopathy	192
Defining iron deficiency in patients with heart failure	188
Electron microscopy of cardiac 3D nanodynamics: form, function, future	183
Factor XI inhibitors in patients with cardiovascular disease and a high risk of bleeding: a cautionary tale	181
Maternal cardiovascular disorders before and during pregnancy and offspring cardiovascular risk across the life course	180
Contemporary coronary artery bypass graft surgery and subsequent percutaneous revascularization	175

Hallmarks of cardiovascular ageing	172
PPAR control of metabolism and cardiovascular functions	164
Neuromodulation reduces inflammation in HFpEF	150
Graded exercise therapy should not be recommended for patients with post-exertional malaise	148
A fatty acid from mother’s milk drives cardiomyocyte maturation in newborn mice	148
Targeting immune cell recruitment in atherosclerosis	147
Decongestion in heart failure: medical and device therapies	145
Extracellular matrix in vascular homeostasis and disease	145
Genomic enhancers in cardiac development and disease	136
Increasing representation and diversity in cardiovascular clinical trial populations	134
Colchicine in acute coronary syndromes: the present and the possible future	132
A tailored cardiac rehabilitation for patients with acute heart failure	127
Preparticipation screening reduces SCD in young athletes	126
Increased degradation of desmosomal proteins in ACM	123
CSDE1 regulates LDL receptor levels	120
Catheter ablation improves outcomes in patients with AF and end-stage HF	119
No benefit of apoA-I infusion after myocardial infarction	113
Identifying leukocyte phenotypes by scRNA-seq to predict cardiovascular risk	110
The oral microbiome in the pathophysiology of cardiovascular disease	107
Prevention of atherosclerosis from childhood	106
Treatment of mild chronic hypertension in pregnancy reduces pre-eclampsia risk	102
Reactive oxygen species in hypertension	102
Semaglutide is beneficial in patients with HFpEF and obesity	99
RNA interference lowers triglyceride levels	97
Modelling pre-eclampsia and its cardiovascular effects	96
Not a spectator sport: improving participation of Black patients in cardiovascular clinical trials	96
Reply to ‘Graded exercise therapy should not be recommended for patients with post-exertional malaise’	95
Donor macrophages influence rejection of transplanted hearts	91
Bempedoic acid prevents cardiovascular events in statin-intolerant patients	91
Unlocking excellence in health care: the power of inclusive and sensitive language in medicine	88
Cardiac sarcomere turnover by unidirectional replacement of proteins	88
Promising novel siRNA for the treatment of hypertension	86
Evidence does not support the reduction of added sugar intake from all food sources	84
Global epidemiology of heart failure	83
BP management with a village-doctor-led strategy	83
Single-cell profiles of CHD and CM	81
An epigenome editing approach induces durable silencing of Pcsk9	78
CV benefits of finerenone in T2DM and CKD	77
Computational modelling of cardiovascular pathophysiology to risk stratify commercial spaceflight	76
Author Correction: The contribution of amyloid deposition in the aortic valve to calcification and aortic stenosis	72
Simvastatin protects against endothelial dysfunction via epigenetic mechanisms	72
Novel factor XIa inhibitor reduces bleeding compared with apixaban in atrial fibrillation	71
The role of the molecular autopsy in sudden cardiac death in young individuals	69
Heart transplantation: advances in expanding the donor pool and xenotransplantation	68